Detalles de la búsqueda
1.
Intervertebral fusion sites in patients with ankylosing spondylitis: A computed tomography study.
Mod Rheumatol
; 34(3): 599-606, 2024 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37489809
2.
Factors associated with discrepancies in disease activity as assessed by SDAI and RAPID3 in patients with rheumatoid arthritis: Data from a multicenter observational study (T-FLAG).
Mod Rheumatol
; 2024 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38727542
3.
Comparison of effectiveness of methotrexate in patients with late-onset versus younger-onset rheumatoid arthritis: Real-world data from an inception cohort in Japan (NICER-J).
Mod Rheumatol
; 2024 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38491996
4.
Increased prevalence of Staphylococcus aureus nasal carriage in rheumatoid arthritis patients with moderate/high disease activity.
J Orthop Sci
; 28(6): 1400-1406, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36210264
5.
Associations of frailty with RA-ILD and poor control of disease activity in patients with rheumatoid arthritis: A multi-center retrospective observational study.
J Orthop Sci
; 2023 Dec 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38044213
6.
Choice of and response to treatment in patients with early-diagnosed rheumatoid arthritis: Real-world data from an inception cohort in Japan (NICER-J).
J Orthop Sci
; 2023 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37076376
7.
Factors associated with frailty in rheumatoid arthritis patients with decreased renal function.
Mod Rheumatol
; 33(2): 323-329, 2023 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35459952
8.
Age and symptoms at onset of ankylosing spondylitis in Japanese patients.
Mod Rheumatol
; 33(4): 817-822, 2023 Jul 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35919934
9.
Effectiveness of tacrolimus concomitant with biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
Mod Rheumatol
; 33(2): 292-301, 2023 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35289372
10.
Reasons and risk factors for discontinuation of treatment with any biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: A long-term observational study.
Mod Rheumatol
; 33(5): 891-898, 2023 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35975317
11.
Disease activity at baseline is an independent predictor of frailty at one year in pre-frail patients with rheumatoid arthritis; a multicenter retrospective observational study.
J Orthop Sci
; 2022 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36460559
12.
Relationship between locomotive syndrome and frailty in rheumatoid arthritis patients by locomotive syndrome stage.
Mod Rheumatol
; 32(3): 546-553, 2022 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34897498
13.
Metabolic changes in synovial cells in early inflammation: Involvement of CREB phosphorylation in the anti-inflammatory effect of 2-deoxyglucose.
Arch Biochem Biophys
; 708: 108962, 2021 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34116007
14.
Relationship between disease activity of rheumatoid arthritis and development of locomotive syndrome: A five-year longitudinal cohort study.
Mod Rheumatol
; 31(1): 101-107, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32186235
15.
Higher doses of methotrexate associated with discontinuation of oral glucocorticoids after initiation of biological DMARDs: A retrospective observational study based on data from a Japanese multicenter registry study.
Mod Rheumatol
; 31(4): 796-802, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33492191
16.
Chondroprotective effects of 4-methylumbelliferone and hyaluronan synthase-2 overexpression involve changes in chondrocyte energy metabolism.
J Biol Chem
; 294(47): 17799-17817, 2019 11 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31619518
17.
Hyaluronan synthase 2 (HAS2) overexpression diminishes the procatabolic activity of chondrocytes by a mechanism independent of extracellular hyaluronan.
J Biol Chem
; 294(37): 13562-13579, 2019 09 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-31270213
18.
Improvement in matrix metalloproteinase-3 independently predicts low disease activity at 52 weeks in bio-switch rheumatoid arthritis patients treated with abatacept.
Clin Exp Rheumatol
; 38(5): 933-939, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32083543
19.
Characteristics of patients with rheumatoid arthritis undergoing primary total joint replacement: A 14-year trend analysis (2004-2017).
Mod Rheumatol
; 30(4): 657-663, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31393198
20.
Simvastatin promotes restoration of chondrocyte morphology and phenotype.
Arch Biochem Biophys
; 665: 1-11, 2019 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30776329